Find your next paid study

University of Southern CaliforniaNCT07186699

~$10 – $750

Observational Study of Urine Metabolites in the Diagnosis of Disease

The goal of this observational study is to validate a non-invasive, urine-based diagnostic technology for the detection and differentiation of various gastroin…

Colorectal CancerSmall Intestinal Bacterial Overgrowth Syndrome (SIBO)Crohn Disease+1 more

Luventix, Inc.NCT06710067

~$10 – $1,050

Phase 1

An Open-label, Multicenter, Phase 1/2a Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumour Activity of WEF-001 in Participants With Advanced KRAS- Mutant Solid Tumours.

This is a study designed to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of WEF-001 as monotherapy in patients with Advanced KRAS…

Advanced or Metastatic KRAS-mutant Tumor in Pancreatic AdenocarcinomaAdvanced or Metastatic KRAS-mutant Tumor in Colorectal CancerAdvanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer+2 more

Auricula Biosciences Inc.NCT07148128

~$10 – $8,750

Phase 1

A Phase 1a/1b Study of 27T51, an Anti-MUC16 CAR T Cell Drug Product Administered Alone or in Combination for Participants With Recurrent or Refractory Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

This study is researching an experimental CAR T cell therapy called 27T51, referred to as study drug. The study drug is a MUC16 targeting immune cell therapy f…

Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer

Regeneron PharmaceuticalsNCT06469281

~$10 – $8,750

Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Grid Radiotherapy for Advanced Non-Small Cell Lung Cancer at the Time of Progression on Immune Checkpoint Inhibition

This phase II trial tests the safety and effectiveness of the combination of grid radiation therapy and standard of care (SOC) immunotherapy in treating patien…

Mayo ClinicNCT06660407

Non Small Cell Lung CancerSmall-cell Lung Cancer

A Phase II Study of Fingolimod in Patients With Non-Small Cell and Small Cell Lung Cancer

This is a single-institution, open-labeled study using fingolimod (FTY720/Gilenya) in patients with non-small cell lung cancer (NSCLC) and small cell lung canc…

Medical University of South CarolinaNCT06424067

Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state…

Pediatric ALLInfant DevelopmentNeurodevelopmental Disorders

University of PennsylvaniaNCT04321200

~$10 – $750

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more

Phase II Trial of Photon Craniospinal Irradiation for Leptomeningeal Disease Secondary to Solid Tumor Malignancy

This phase II trial tests how well craniospinal irradiation (CSI) using photon volumetric modulated arc radiotherapy (VMAT) works in treating patients with bre…

City of Hope Medical CenterNCT06910761

Observational

Neonatal Platelet Transfusion Threshold Trial

The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion…

ThrombocytopeniaNeonatalPlatelet Transfusion+4 more

NICHD Neonatal Research NetworkNCT06676904

~$10 – $7,500

Observational

Comparing the Stanford Letter Project Form to Traditional Advance Directives

Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.

Advance DirectivesPalliative Care

Stanford UniversityNCT02799537

Phase 1

A Phase I Trial of CD19-targeted Chimeric Antigen Receptor (CAR) T Cells That Constitutively Secrete Interleukin 18 (19-28z/IL-18) in Patients With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sen…

Philadelphia-Negative ALLPhiladelphia-Positive ALLRelapsed ALL, Adult+3 more

Memorial Sloan Kettering Cancer CenterNCT06287528

Triple Negative Breast CancerNon Small Cell Lung CancerMetastatic Breast Cancer+1 more

PROMISE-005: A Phase II Randomized Study Assessing the Efficacy of Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Breast or Lung Cancer

This study is being done to determine if stereotactic body radiotherapy (SBRT) when delivered to all sites of disease in participants with 1-5 metastases will …